NL-OMON34440已完成不适用
PLASMA CONCENTRATION, EXCRETION AND MASS BALANCE OF ORALLY ADMINISTERED 14C-FYX-051 IN HEALTHY MALE SUBJECTS - 14C-FYX-051 ADME STUDY
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- healthy male
- •- you are between 20 and 35 years of age;
- •- your BMI is between 18.0 and 30.0 kg/m2 (to calculate your BMI (Body Mass Index): divide your weight (in kg) by your squared length in meters (weight / (length x length));
- •- you do not smoke or are a moderate smoker (please note that during your stay in the clinical research centre and in the 48h-period prior to your stay, smoking is not allowed)
排除标准
- •Suffering from: hepatitis B, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 90 days from the start of the study. In case of donating more than 1.5 liters of blood in the 12 months prior the start of this study. Participation is also not permitted when participated in more than 3 other drug studies in the 10 months prior to the start of this study.
研究者
相似试验
已完成
不适用
Excretion balance, pharmacokinetics and metabolism of S 47445 after single oral administration of 20mg [14C]-S 47445 in young healthy male volunteers.dementiaNL-OMON35510Institut de Recherches Internationales Servier I.R.I.S4
已完成
不适用
Excretion balance, pharmacokinetics and metabolism of S44819 after single administration of [14C]-S44819 in young healthy male volunteers. A phase 1 monocentre open-label study.strokeNL-OMON44446Institut de Recherches Internationales Servier (I.R.I.S.)4
已完成
不适用
Excretion balance, pharmacokinetics and metabolism of S 38844 after single oral dose administration of [14C]-S 38844 in healthy male volunteers.cardiovascular diseasesheart- and (blood) vessel diseases1008220610057166NL-OMON36850Institut de Recherches Internationales Servier I.R.I.S6
进行中（未招募）
不适用
MESURE ET COMPARAISON DES CONCENTRATIONS PLASMATIQUES ARTERIELLES ET VEINEUSES DE PROPOFOL CHEZ DES PATIENTS DE REANIMATION SOUS SEDATION PAR LE SYSTEME AIVOC.patient de réanimation sous ventilation artificielle nécessitant une sédation de 24hEUCTR2006-005770-44-FRCHU Clermont-Ferrand
已完成
1 期
Mass Balance, Pharmacokinetics and Metabolism Study of AlisertibAdvanced Solid TumorsLymphomaNCT01714947Millennium Pharmaceuticals, Inc.3